The Longevity Health Company (TLHC) Stock Statistics & Valuation Metrics
Total Valuation
The Longevity Health Company has a market cap or net worth of $1.74M. The enterprise value is $3.69T.
- Market Cap
- $1.74M
- Enterprise Value
- $3.69T
Share Statistics
The Longevity Health Company has 188,808,170 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 188,808,170
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
The Longevity Health Company’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 0.44%.
- Return on Equity (ROE)
- 0.04
- Return on Assets (ROA)
- -40.35
- Return on Invested Capital (ROIC)
- 0.44%
- Return on Capital Employed (ROCE)
- 0.00
- Revenue Per Employee
- 0
- Profits Per Employee
- -189.00K
- Employee Count
- 2
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of The Longevity Health Company is 304.53. The Longevity Health Company’s PEG ratio is 3.05.
- PE Ratio
- 304.53
- PS Ratio
- 2643.31
- PB Ratio
- -0.16
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- 3.05
Income Statement
In the last 12 months, The Longevity Health Company had revenue of 0 and earned -378.00K in profits. Earnings per share was 0.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -23.54K
- Pretax Income
- -378.00K
- Net Income
- -378.00K
- EBITDA
- -23.54K
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was 2,796 and capital expenditures 0, giving a free cash flow of 2,796 billion.
- Operating Cash Flow
- 2,796
- Free Cash Flow
- 2,796
- Free Cash Flow per Share
- 0.00
Dividends & Yields
The Longevity Health Company pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 0.33%
Stock Price Statistics
- Beta
- 5.63
- 52-Week Price Change
- -41.18%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- 12.62
- Average Volume (3m)
- 239.60K
Financial Position
The Longevity Health Company as a current ratio of 0.00, with Debt / Equity ratio of -36.41%
- Current Ratio
- 0.00
- Quick Ratio
- 0.00
- Debt to Market Cap
- 0.65
- Net Debt to EBITDA
- -130.20
- Interest Coverage Ratio
- -0.07
Taxes
In the past 12 months, The Longevity Health Company has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
The Longevity Health Company EV to EBITDA ratio is 1010.64, with an EV/FCF ratio of 0.00.
- EV to Sales
- 8772.32
- EV to EBITDA
- 1010.64
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
The Longevity Health Company has -$138.00 in cash and marketable securities with $3.06M in debt, giving a net cash position of -$3.07M billion.
- Cash & Marketable Securities
- -$138.00
- Total Debt
- $3.06M
- Net Cash
- -$3.07M
- Net Cash Per Share
- -$0.02
- Tangible Book Value Per Share
- -$0.04
Margins
Gross margin is 48.00%, with operating margin of 868.00%, and net profit margin of 868.00%.
- Gross Margin
- 48.00%
- Operating Margin
- 868.00%
- Pretax Margin
- 868.00%
- Net Profit Margin
- 868.00%
- EBITDA Margin
- 868.00%
- EBIT Margin
- 868.00%
Analyst Forecast
The average price target for The Longevity Health Company is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
